Yes, p16ink4a has shown promise as a biomarker for various cancers. Its overexpression is often associated with cellular senescence and aging, making it a potential marker for early detection and prognosis. For instance, p16ink4a immunohistochemistry is used in the diagnosis of HPV-related oropharyngeal cancers, as its high expression correlates with better clinical outcomes.
